Follow Us
  • Facebook Basic Black
  • Twitter Basic Black
  • LinkedIn Social Icon

"Insulin sensitizer in prediabetes"


"The aim of this paper is to evaluate the efficacy and safety of DLBS3233, a novel bioactive fraction derived from Cinnamomum burmanii andLagerstroemia speciosa, in improving insulin resistance and preserving β-cell performance in patients with impaired glucose tolerance (IGT)." (1)

Click here to read the full article

Source- (1) https://www.dovepress.com/insulin-sensitizer-in-prediabetes-a-clinical-study-with-dlbs3233-a-com-peer-reviewed-article-DDDT

#InsulinSensitizer #PreDiabetes #insulin #Insulinresistance #Impairedglucosetolerance

Must Read

Awards & Honors

All Contents © Copyright Epinex Diagnostics, Inc. 2011. All Rights Reserved